BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 37936611)

  • 1. Corrigendum: A novel
    Colombo M; Mondini P; Minenza E; Foglia C; Mosconi A; Molica C; Pistola L; Ludovini V; Radice P
    Front Oncol; 2023; 13():1306238. PubMed ID: 37936611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel
    Colombo M; Mondini P; Minenza E; Foglia C; Mosconi A; Molica C; Pistola L; Ludovini V; Radice P
    Front Oncol; 2023; 13():1102184. PubMed ID: 37025588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double Heterozygosity for BRCA1 Pathogenic Variant and BRCA2 Polymorphic Stop Codon K3326X: A Case Report in a Southern Italian Family.
    Palmirotta R; Lovero D; Stucci LS; Silvestris E; Quaresmini D; Cardascia A; Silvestris F
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29346284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRCA1 deficiency is a recurrent event in early-onset triple-negative breast cancer: a comprehensive analysis of germline mutations and somatic promoter methylation.
    Brianese RC; Nakamura KDM; Almeida FGDSR; Ramalho RF; Barros BDF; Ferreira ENE; Formiga MNDC; de Andrade VP; de Lima VCC; Carraro DM
    Breast Cancer Res Treat; 2018 Feb; 167(3):803-814. PubMed ID: 29116469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A de Novo BRCA1 Pathogenic Variant in a 29-Year-Old Woman with Triple-Negative Breast Cancer.
    Gebhart P; Tan Y; Muhr D; Stein C; Singer C
    Breast Care (Basel); 2023 Oct; 18(5):412-416. PubMed ID: 37901051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening of
    Montalban G; Bonache S; Moles-Fernández A; Gisbert-Beamud A; Tenés A; Bach V; Carrasco E; López-Fernández A; Stjepanovic N; Balmaña J; Diez O; Gutiérrez-Enríquez S
    J Med Genet; 2019 Feb; 56(2):63-74. PubMed ID: 30472649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double heterozygous mutation in the BRCA1 and ATM genes involved in development of primary metachronous tumours: a case report.
    Andrés R; Menao S; Arruebo M; Quílez E; Cardiel MJ
    Breast Cancer Res Treat; 2019 Oct; 177(3):767-770. PubMed ID: 31292799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of the ATM IVS10-6T-->G variant in Australian multiple-case breast cancer families.
    Lindeman GJ; Hiew M; Visvader JE; Leary J; Field M; Gaff CL; Gardner RJ; Trainor K; Cheetham G; Suthers G; Kirk J
    Breast Cancer Res; 2004; 6(4):R401-7. PubMed ID: 15217508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spliceogenic analysis of BRCA1 c.439T>C (rs794727800) variant by High Resolution Melting Analysis.
    Minucci A; Mazzuccato G; D'Indinosante M; Di Nardo L; Concolino P; De Bonis M; Urbani A; Scambia G; Fagotti A; Capoluongo E
    Mol Biol Rep; 2020 Feb; 47(2):1513-1520. PubMed ID: 31833030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathological features of breast cancer in carriers of ATM gene variants.
    Balleine RL; Murali R; Bilous AM; Farshid G; Waring P; Provan P; Byth K; Thorne H; ; Kirk JA
    Histopathology; 2006 Nov; 49(5):523-32. PubMed ID: 17064299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adolescent triple-negative breast cancer with germline pathogenic variants in both
    Chen D; Zhang C; Yuan M; Zhang Y; Liu Q; Wan D
    Front Oncol; 2022; 12():970641. PubMed ID: 36518309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of ATM germline variants by the p53 mitotic centrosomal localization test in BRCA1/2-negative patients with early-onset breast cancer.
    Prodosmo A; Buffone A; Mattioni M; Barnabei A; Persichetti A; De Leo A; Appetecchia M; Nicolussi A; Coppa A; Sciacchitano S; Giordano C; Pinnarò P; Sanguineti G; Strigari L; Alessandrini G; Facciolo F; Cosimelli M; Grazi GL; Corrado G; Vizza E; Giannini G; Soddu S
    J Exp Clin Cancer Res; 2016 Sep; 35(1):135. PubMed ID: 27599564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation Treatment, ATM, BRCA1/2, and CHEK2*1100delC Pathogenic Variants and Risk of Contralateral Breast Cancer.
    Reiner AS; Robson ME; Mellemkjær L; Tischkowitz M; John EM; Lynch CF; Brooks JD; Boice JD; Knight JA; Teraoka SN; Liang X; Woods M; Shen R; Shore RE; Stram DO; Thomas DC; Malone KE; Bernstein L; Riaz N; Woodward W; Powell S; Goldgar D; Concannon P; ; Bernstein JL
    J Natl Cancer Inst; 2020 Dec; 112(12):1275-1279. PubMed ID: 32119081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variants of prospectively demonstrated phenocopies in
    Dominguez-Valentin M; Evans DGR; Nakken S; Tubeuf H; Vodak D; Ekstrøm PO; Nissen AM; Morak M; Holinski-Feder E; Martins A; Møller P; Hovig E
    Hered Cancer Clin Pract; 2018; 16():4. PubMed ID: 29371908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minigene-based splicing analysis and ACMG/AMP-based tentative classification of 56 ATM variants.
    Bueno-Martínez E; Sanoguera-Miralles L; Valenzuela-Palomo A; Esteban-Sánchez A; Lorca V; Llinares-Burguet I; Allen J; García-Álvarez A; Pérez-Segura P; Durán M; Easton DF; Devilee P; Vreeswijk MP; de la Hoya M; Velasco-Sampedro EA
    J Pathol; 2022 Sep; 258(1):83-101. PubMed ID: 35716007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary breast and ovarian cancer: assessment of point mutations and copy number variations in Brazilian patients.
    Silva FC; Lisboa BC; Figueiredo MC; Torrezan GT; Santos EM; Krepischi AC; Rossi BM; Achatz MI; Carraro DM
    BMC Med Genet; 2014 May; 15():55. PubMed ID: 24884479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between BRCA-associated breast cancer and age factors: an analysis of the Japanese HBOC consortium database.
    Okano M; Nomizu T; Tachibana K; Nagatsuka M; Matsuzaki M; Katagata N; Ohtake T; Yokoyama S; Arai M; Nakamura S
    J Hum Genet; 2021 Mar; 66(3):307-314. PubMed ID: 33046835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Application of next-generation sequencing in detection of BRCA1/2 and homologous recombination repair pathway multi-genes germline mutation and correlation analysis].
    Chen YL; Zhuo ZL; Liu C; Xie F; Yang ZY; Liu PF; Wang S; Zhao XT
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Mar; 56(3):302-311. PubMed ID: 35381651
    [No Abstract]   [Full Text] [Related]  

  • 19. Contribution of mutations in ATM to breast cancer development in the Czech population.
    Soukupova J; Dundr P; Kleibl Z; Pohlreich P
    Oncol Rep; 2008 Jun; 19(6):1505-10. PubMed ID: 18497957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a novel pathogenic variant in
    Laraqui A; Cavaillé M; Uhrhammer N; ElBiad O; Bidet Y; El Rhaffouli H; El Anaz H; Rahali DM; Kouach J; Guelzim K; Badaoui B; AlBouzidi A; Oukabli M; Tanz R; Sbitti Y; Ichou M; Ennibi K; Sekhsokh Y; Bignon YJ
    J Genomics; 2021; 9():43-54. PubMed ID: 34646395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.